Maimonides Institute for Biomedical Research of Córdoba, Cordoba, Spain.
Nuclear Medicine Service, Virgen del Rocio University Hospital, Seville, Spain.
Front Endocrinol (Lausanne). 2022 Jan 26;12:812385. doi: 10.3389/fendo.2021.812385. eCollection 2021.
Hypercalcemia is a common complication in cancer patients Mainly caused by Parathyroid hormone-related protein (PTHrP) secretion and metastasis. Calcitriol secretion is a rare source of hypercalcemia in solid tumors, especially in gastrointestinal stromal tumors (GIST). We present a case report of a female patient with a 23 cm gastric GIST that expressed somatostatin-receptors and presented with severe hypercalcemia due to calcitriol secretion. Calcium control was achieved with medical treatment before the use of targeted-directed therapies. Surgery was performed and allowed complete tumor resection. Two years later, patient remains free of disease. Molecular analysis revealed the mRNA expression of 25-hydroxyvitamin D-1-hydroxylase (1αOHase) and vitamin-D receptors in the tumor cells, confirming the calcitriol-mediated mechanism. Furthermore, the expression of the endotoxin recognition factors CD14 and TLR4 suggests an inflammatory mediated mechanism. Finally, the expression of somatostatin-receptors, especially might have been related with clinical evolution and prognosis in this patient.
高钙血症是癌症患者的常见并发症,主要由甲状旁腺激素相关蛋白(PTHrP)分泌和转移引起。1,25-二羟维生素 D3(calcitriol)分泌是实体瘤,特别是胃肠道间质瘤(GIST)中高钙血症的罕见来源。我们报告了一例女性患者,其胃 GIST 长 23 厘米,表达生长抑素受体,并因 1,25-二羟维生素 D3 分泌而出现严重高钙血症。在使用靶向治疗之前,通过药物治疗控制了钙水平。手术完成并允许完全切除肿瘤。两年后,患者无病生存。分子分析显示肿瘤细胞中 25-羟维生素 D-1-羟化酶(1αOHase)和维生素 D 受体的 mRNA 表达,证实了 1,25-二羟维生素 D3 介导的机制。此外,内毒素识别因子 CD14 和 TLR4 的表达表明存在炎症介导的机制。最后,生长抑素受体的表达,特别是 SSTR2,可能与该患者的临床演变和预后有关。